Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS  + EG score

ConclusionThe CPS  + EG score, originally designed to predict distant relapse, is also valuable for assessing local recurrence risks. Our data demonstrate that distant and locoregional recurrence risks are closely related. As prognosis of patients with high risk of locoregional failure based on CPS + EG is do minated by distant recurrences, escalating local therapies may have limited impact on overall prognosis.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research